Replimune gets third chance at US approval for skin cancer drug - Reuters
Reuters reports on Replimune gets third chance at US approval for skin cancer drug in Science & Health.
Take A Coffee NEWS Staff··2 min read
Reuters reported Replimune gets third chance at US approval for skin cancer drug. Take A Coffee NEWS is tracking the story on the Science & Health desk for readers following medicine, public health, research, climate, space, and science policy.
Source
Why it matters
The story belongs in this desk because it may affect readers tracking medicine, public health, research, climate, space, and science policy.